Diabetes Mellitus and CKD Awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)

American Journal of Kidney Diseases

Volumn 53, Issue 4 SUPPL. 4, 2009, Pages

  Whaley Connell, Adam ^a   Sowers, James R ^a   McCullough, Peter A ^b   Roberts, Tricia ^c   McFarlane, Samy I ^d   Chen, Shu Cheng ^c   Li, Suying ^c   Wang, Changchun ^c   Collins, Allan J ^c   Bakris, George L ^e  

^a University of Missouri   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chronic kidney disease; diabetes; health screening

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE;

ADULT; AGED; ARTICLE; AWARENESS; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MALE; RISK FACTOR; SELF REPORT; URINALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AWARENESS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE, CHRONIC; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; UNITED STATES; YOUNG ADULT;

EID: 61749103126     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.004     Document Type: Article

References (36)

1. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49 suppl 2 (2007) S12-S154
2. US Renal Data System. USRDS 2006 Annual Data Report (2006), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
3. Fox C.S., Larson M.G., Leip E.P., et al. Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care 28 (2005) 2436-2440
4. Bianchi C., Miccoli R., Penno G., et al. Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care 31 suppl 2 (2008) S208-S214
5. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140 (2004) 167-174
6. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
7. Lea J., Cheek D., Thornley-Brown D., et al. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 51 (2008) 732-740
8. Lucove J., Vupputuri S., Heiss G., et al. Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis 51 (2008) 21-28
9. Whaley-Connell A., Pavey B.S., Afroze A., et al. Obesity and insulin resistance as risk factors for chronic kidney disease. J Cardiometab Syndr 1 (2006) 209-214
10. Hovind P., Rossing P., Tarnow L., et al. Progression of diabetic nephropathy. Kidney Int 59 (2001) 702-709
11. Fioretto P., Bruseghin M., Berto I., et al. Renal protection in diabetes: Role of glycemic control. J Am Soc Nephrol 17 suppl 2 (2006) S86-S89
12. Menon V., Greene T., Pereira A.A., et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 16 (2005) 3411-3417
13. Kinchen K.S., Sadler J., Fink N., et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137 (2002) 479-486
14. Cleveland D.R., Jindal K.K., Hirsch D.J., et al. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis 40 (2002) 30-36
15. Brown W.W., Peters R.M., Ohmit S.E., et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42 (2003) 22-35
16. Brown W.W., Collins A., Chen S.C., and e.a. Identification of persons at high risk for kidney disease via targeted screening: The NKF Kidney Early Evaluation Program. Kidney Int Suppl 83 (2003) S50-S55
17. Jurkovitz C.T., Qiu Y., Wang C., et al. The Kidney Early Evaluation Program (KEEP): Program design and demographic characteristics of the population. Am J Kidney Dis 51 suppl 2 (2008) S3-S12
18. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
19. Stevens L.A., and Stoycheff N. Standardization of serum creatinine and estimated glomerular filtration rate in the National Kidney Foundation Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 51 suppl 2 (2008) S77-S82
20. National Kidney Foundation. What Is the Kidney Early Evaluation Program (KEEP)?. http://www.kidney.org/news/keep/KEEPabout.cfm Accessed January 7, 2009
21. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 (2003) 2560-2572
22. Sarafidis P.A., Li S., Chen S.C., et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 121 (2008) 332-340
23. Saab G., Whaley-Connell A.T., McCullough P.A., et al. CKD awareness in the United States: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 52 (2008) 382-383
24. McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 167 (2007) 1122-1129
25. Whaley-Connell A.T., Sowers J.R., McFarlane S.I., et al. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51 suppl 2 (2008) S21-S29
26. Chen J., Muntner P., Hamm L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 (2003) 469-477
27. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
28. McGill J.B., Brown W.W., Chen S.C., et al., Kidney Early Evaluation Program (KEEP). Findings from a community screening program. Diabetes Educ 30 (2004) 196-206
29. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis 42 suppl 4 (2003) S3-S60
30. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis 45 suppl 2 (2005) S1-S136
31. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis 46 suppl 3 (2005) S1-S158
32. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis 49 suppl 3 (2007) S1-S160
33. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. 2003. Department of Health and Human Services. http://www.cdc.gov/diabetes/pubs/factsheet.htm Accessed January 7, 2009
34. US Department of Health and Human Services. Healthy People 2010, Diabetes Progress Review 2002 (2002), US Government Printing Office, Washington, DC
35. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
36. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853